Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma
Condition: Peripheral T Cell Lymphoma Intervention: Drug: CAR-T Therapy Sponsor: Zhao Weili Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials